In the BioHarmony Drug Report Database

"Preview" Icon

Epoetin alfa

Epogen/Procrit, Procrit (epoetin alfa) is a protein pharmaceutical. Epoetin alfa was first approved as Epogen/Procrit on 1989-06-01. It is used to treat anemia in the USA. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms. It is known to target erythropoietin receptor.

 

Trade Name

 

Epogen/Procrit, Procrit
 

Common Name

 

epoetin alfa
 

ChEMBL ID

 

CHEMBL1201565
 

Indication

 

anemia, chronic kidney failure, neoplasms
 

Drug Class

 

Erythropoietins

Image (chem structure or protein)

Epoetin alfa structure rendering